Page 1 of 3
123

2026 (4 POSTS)

Wikoff D, Fitch S, Eichenbaum G, Ejaz S, Klaren W, Southall M. Need for fit-for-purpose approaches that integrate dose, mechanism, and context of use with key characteristics when evaluating the carcinogenic potential of widely used therapeutics: A case study of acetaminophen. Abstract 4005, Society of Toxicology 65th Annual Meeting, San Diego, CA, March 2026.

Vincent M, Wheeler M, Schaefer H, Rhoden J,  Fitch S, Wikoff D. Quantitative bias assessment to facilitate assessment of (un)certainty in observational data evaluating acetaminophen use and liver cancer. Abstract 4279, Society of Toxicology 65th Annual Meeting, San Diego, CA, March 2026.

Klaren WD, Rivera BN, Sheppard AM, Franke K, Wikoff DS. Approach for systematically assessing study reliability and relevance in evaluations of monosodium glutamate safety. Abstract 3653, Society of Toxicology 65th Annual Meeting, San Diego, CA, March 2026.

View Abstract

Buerger AN, Lea IA, Vincent MJ,…, Choksi NY, Britt J, Fitch S, Rogers S, Schaefer H, Haws L,…, Wikoff D, Borghoff SJ. Systematic evaluation of the carcinogenic potential of di-isononyl phthalate in humans. Abstract 3314, Society of Toxicology 65th Annual Meeting, San Diego, CA, March 2026.

View Abstract

2025 (6 POSTS)

Verwiel A, Rish W. Importance of integrating cumulative chemical exposures into cumulative impact assessment for vulnerable communities. Session T1-A, Society for Risk Analysis (SRA) Annual Meeting, Washington, DC, December 2025.

View Abstract

Franke K, Panko J, Hidding B, DeLee M, Davis CW, Norman J. Development of a database for identification, hazard assessment and risk assessment support for plastic additives in commerce. Abstract 7.04.P-Tu-126, SETAC North America 46th Annual Meeting, Portland, OR, November 2025.

View Abstract

Rish W, Verwiel A. Importance of epidemiology and visualization to integrate non-chemical stressors into cumulative impact assessment for vulnerable communities. Abstract 568/Poster P47-17, International Society of Exposure Science and International Society for Environmental Epidemiology (ISES/ISEE) Joint Annual Meeting, Atlanta, GA, August 2025.

View Abstract

Diemar MG, Giusti A, Michel-Caillet C, Leme DM, Wikoff D, Bloch D, Sass J, Beekmann K, et al. 2025. How to organize a successful toxicology workshop? A participant perspective on the Collaboration to Harmonise the Assessment of Next Generation Evidence (CHANGE) workshop in Oslo, 18-20 June 2024. Arch Toxicol 99(7):3057-3063; doi: 10.1007/s00204-025-04064-6. PMID: 40372420.

View Abstract

Jacobellis M, Garcia M, Bain L, Pearce J, Hunt K, Baldwin W. Disruption of energy homeostasis by chemical mixtures containing persistent pollutants in HepG2 and C2C12 cells. Abstract 4564, Society of Toxicology 64th Annual Meeting, Orlando, FL, March 2025.

View Abstract

Covell LT, Han AA, Blanchette AD, Madl AK. Comparison of harmful and potentially harmful constituents (HPHC) and associated excess lifetime cancer risks (ELCR) across oral nicotine products. Abstract 4911, Society of Toxicology 64th Annual Meeting, Orlando, FL, March 2025.

2024 (1 POST)

Franke K, Vincent M, Rogers S, Rivera B, Wikoff D. Assessment of non-occupational exposures to cleaning products and the incidence of asthma and respiratory disease. Abstract 3393, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.

View Abstract

2023 (2 POSTS)

Nyffeler J, Willis C, Harris FR, Foster MJ, Chambers B, Culbreth M, Brockway RE,…, Patlewicz G, et al. 2023. Application of cell painting for chemical hazard evaluation in support of screening-level chemical assessments. Toxicol Appl Pharmacol 468(June 1):116513; doi: 10.1016/j.taap.2023.116513. PMID: 37044265.

View Abstract

Houck K, Paul Friedman K, Feshuk M, Patlewicz G, Smeltz M, Clifton S, Wetmore BA, Velichko S, et al. 2023. Evaluation of 147 perfluoroalkyl substances for immunotoxic and other (patho)physiological activities through phenotypic screening of human primary cells. ALTEX 40(2):248–270; doi: 10.14573/altex.220304. PMID: 36129398.

View Abstract

2022 (2 POSTS)

Hoffmann S, Aiassa E, Angrish M, Beausoleil C, Bois FY… Wikoff D, et al. 2022. Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks. ALTEX 39(3):499-518; doi: 10.14573/altex.2202141. PMID: 35258090.

View Abstract

Vincent M, O’Neill HC, Maier A, Buerger AN, Madl AK. Analysis of toxicity assay options for data poor chemical inhalation limit setting: Flavors as a case study. Presented at Tobacco Science Research Conference, 2022.

2021 (3 POSTS)

Lizarraga LE, Patlewicz G, Dean JL II, Zhao QJ, Kaiser JP. 2021. Provisional peer-reviewed toxicity values for 3,4-toluenediamine (CASRN 496-72-0). Cincinnati (OH): U.S. Environmental Protection Agency; 2021 Aug. PMID: 36191119.

O’Neil HC, Vincent MJ, Han AA, Brown SE, Hazell AM, Krieder ML, Madl AM. Hazard and risk banding framework for prioritization and bridging of e-liquids for toxicity testing. Poster presented at Society of Toxicology 60th Annual Meeting, Virtual, March 2021.

View Abstract

Choksi N. Identifying data on your chemical. Continuing Education Course: Rapid Chemical Assessment Using Open Computational Methods, Presented at Society of Toxicology 60th Annual Meeting, Virtual, March 2021.

2020 (3 POSTS)

Bell S, Abedini J, Ceger P, Chang X, Cook B, Karmaus AL, Lea I, Mansouri K, et al. 2020. An integrated chemical environment with tools for chemical safety testing. Toxicol in Vitro 67(Sept):104916; doi: 10.1016/j.tiv.2020.104916. PMID: 32553663.

View Abstract

Pham LL, Borghoff SJ, Thompson CM. 2020. Comparison of threshold of toxicological concern (TTC) values to oral reference dose (RfD) values. Regul Toxicol Pharmacol 113(June):104651; doi: 10.1016/j.yrtph.2020.104651. PMID: 32229245.

View Abstract
Page 1 of 3
123